Oncolytic peptide nanomachine circumvents chemo resistance of renal cell carcinoma.
Sign Up to like & getrecommendations! Published in 2022 at "Biomaterials"
DOI: 10.1016/j.biomaterials.2022.121488
Abstract: Due to intrinsic and acquired chemo/radiotherapy-resistance, renal cell carcinoma shows limited therapeutic response to clinically utilized targeting drugs. Here a tumor-activated oncolytic peptide nanomachine is devised to selectively lysing tumor cell membrane without causing drug… read more here.
Keywords: oncolytic peptide; resistance; peptide nanomachine; tumor ... See more keywords